| 生物活性 | |||
|---|---|---|---|
| 描述 | DAPT (GSI-IX), a powerful and orally bioavailable γ-secretase inhibitor, exhibits IC50 values of 115 nM for total amyloid-β (Aβ) and 200 nM for Aβ42. It blocks Notch 1 signaling activation and promotes cell differentiation. Additionally, DAPT triggers autophagy and apoptosis, offers neuroprotective effects, and holds therapeutic potential for autoimmune, lymphoproliferative disorders, degenerative diseases, and cancer[1][2]. DAPT (GSI-IX) (GMP) refers to DAPT manufactured according to GMP standards. GMP-compliant small molecules function effectively as supporting agents in the production of cell therapies. DAPT acts as a potent, orally administrable γ-secretase inhibitor[1][2]. | ||
| 作用机制 | DAPT targets the C-terminal fragment of PS which represents the catalytic center of γ-secretase, especially the transmembrane domain 7 or more C-terminal region. DAPT can completely abolish the proteolytic activity of γ-secretase.[5][6] | ||
| 细胞研究 | |||||
|---|---|---|---|---|---|
| 细胞系 | 浓度 | 检测类型 | 检测时间 | 活性说明 | 数据源 | 
| A549 | 10 μM | Growth Inhibition Assay | 24h | decreases the cell viability combined with PTE | 23671619 | 
| A549 CD133− | 2 μM | Growth Inhibition Assay | 48 h | enhances cell growth inhibition induced by CDDP | 24502949 | 
| A549 CD133+ | 2 μM | Growth Inhibition Assay | 48 h | enhances cell growth inhibition induced by CDDP | 24502949 | 
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
| 1 mM 5 mM 10 mM | 2.31mL 0.46mL 0.23mL | 11.56mL 2.31mL 1.16mL | 23.12mL 4.62mL 2.31mL | 
| 参考文献 | 
|---|